Match each patient presentation describing a suspected tick-borne illness with the most appropriate targeted antimicrobial therapy.
- A 52-year-old man with a history of splenectomy residing in Massachusetts presents with fever, jaundice, hemolytic anemia, and a peripheral blood smear revealing intraerythrocytic tetrads.Atovaquone and azithromycin
- A 26-year-old woman at 12 weeks gestation residing in Connecticut presents with an asymptomatic, 7-cm expanding erythematous patch with central clearing on her right thigh.Oral amoxicillin
- A 10-year-old boy from North Carolina presents with a high fever, severe headache, and a petechial rash that originated on his wrists and ankles before spreading centrally.Oral doxycycline
- A 33-year-old man from New York presents with progressive fatigue, a unilateral facial nerve palsy, and an electrocardiogram demonstrating a PR interval of 340 milliseconds.Intravenous ceftriaxone
Cevap
The correct pairings appropriately match the specific tick-borne disease presentation with its guideline-directed antimicrobial therapy: babesiosis with atovaquone/azithromycin, Lyme disease in pregnancy with oral amoxicillin, RMSF in a child with oral doxycycline, and severe Lyme carditis with PR prolongation with IV ceftriaxone.
Each clinical scenario requires specific knowledge of antimicrobial guidelines for tick-borne diseases. Babesiosis requires antiprotozoal therapy (atovaquone and azithromycin). Early Lyme disease in pregnancy necessitates amoxicillin due to doxycycline contraindications. Rocky Mountain spotted fever is a medical emergency requiring doxycycline for all ages, including children. Severe Lyme carditis (PR > 300 ms) mandates parenteral therapy with intravenous ceftriaxone.
Adım Adım Çözüm
Anahtar Kavram
Selection of targeted antimicrobial therapy for tick-borne diseases must account for the specific pathogen, disease severity, and patient factors (e.g., age, pregnancy, splenic function).